{"name":"Gritstone bio, Inc.","slug":"gritstone-bio-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQTm1sbGlSOFBSVzVzeFRuWms3aU05c0RXd2NDbnVPQ0RTdUVWSUlfUVdZV1d0S2FrSEwyU1RwM2FfSTlLcFA5cGRYVFlkMHctTXdaNGp4SE56MzUzT28zc3l6TVVzTGlqTGtpbzBGWVR2ejI4UXhKdkdJVzNjZHhrb0JodUoxZXpIN0NpbnphN1JOZHEydHY1VDZXdUE2aGFtbnZ6eVM5Z2Vrd3BiRkpKRnZTWm14ejVaWGVoMzAzTENZd3c?oc=5","date":"2026-03-15","type":"pipeline","source":"AD HOC NEWS","summary":"Gritstone bio Inc Stock (ISIN: US3987021022) Faces Volatility Amid Biotech Sector Pressures - AD HOC NEWS","headline":"Gritstone bio Inc Stock (ISIN: US3987021022) Faces Volatility Amid Biotech Sector Pressures","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE0wZTlEemc0N1hpTzY5S04zSVA2dDg5d2IzMWtfYkJVTGlpMGNuNXIxM3pFOTBuWVpJeVdPY0tQb1A0dk45UUVkb0FlVUVyWkJIVDFOWEFaR2RhcWxhRThwU09IZlBoemdWQlh5WFNWaGhRdDFCZ28yQQ?oc=5","date":"2025-05-06","type":"trial","source":"Insightace Analytic","summary":"KRAS Inhibitors Market Size, Share, Scope, Trends Study - Insightace Analytic","headline":"KRAS Inhibitors Market Size, Share, Scope, Trends Study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBHUnpvMTNWVXg4ZDJkLVE1M2cwNUlqOVp5RTcxcndyMU5CcG9Tc1A0MEd4VHVnUWdHNWtvY0NaQnh5RnAxUVFoeVZZbVFZckVpekVB?oc=5","date":"2025-04-24","type":"pipeline","source":"Stock Titan","summary":"AMPE Stock Price, News & Analysis - Stock Titan","headline":"AMPE Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxONDdSUlR0NTNpOEtwRTgzeWpUR1d2LUxtb0VQTEt2UndQdmlYTGQ1SHlEUXZSeGtvQThXMm1CZGNZZXZGTEVJQjZEMEp0Q25DZWlTZnYxcnZ0ZEJkanFYbE5IQlMteUUxdWliemhXSmR2WXZMRGQtVlB3NzZ0eXdvY1JvUjI1c0pMaXYxSXZBNl9wS2hJa01JNjA4R3UxQk0?oc=5","date":"2025-02-19","type":"pipeline","source":"BioSpace","summary":"Biopharma Bankruptcies Still At Peak, With Little Relief in Sight - BioSpace","headline":"Biopharma Bankruptcies Still At Peak, With Little Relief in Sight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQYWpySm1rQ1V0TVUtQ3FYaXVjS3R0V1VXZEdpd3gwUk1nRU1MM3pvcUlZanl6VndTSmJvZmRrT0E4Q0ZibHAtR1diVFBJc05vVlM2NlBjTWNCYUV5UlFGU3RBZmpBMG1lWjh6RWNXTFJicjdkMkpMMnd5TlZOVjZwNTJMYng2eGlkSzVNc1JoSkxPZTd5SVJxSDdpU3RJVFJXVWJUZA?oc=5","date":"2024-10-10","type":"pipeline","source":"Fierce Biotech","summary":"Gritstone files for bankruptcy in hope of keeping cancer vaccine R&D afloat - Fierce Biotech","headline":"Gritstone files for bankruptcy in hope of keeping cancer vaccine R&D afloat","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxQNnhZbmlqOEM0bUxReTJTallhN0Q1R3BIR3hjS3ZWbExramc3YlhOLTlwZDU3aHpKX1M0bzJBSDRSVVV5RGxEaVpMTnZLX2djTlhzd2pNVzM1SU9JTlMtaktzT01od2dTX21mTE1WUnc0bm1FdS1sRFVJUWFzN1JzQ1VDQmpkcWVYOHZkMlFNZ1BfOEljNi1oekZReUN2UWZ5YmF0bUs3N2NYaTdBVVJhbU9Gb0NzQ0hpSnp0YllsUXZGX2UwQmVlX0hyd21XV3M?oc=5","date":"2024-10-10","type":"pipeline","source":"Business Wire","summary":"Gritstone bio Takes Action to Preserve Value and Strengthen Capital Structure - Business Wire","headline":"Gritstone bio Takes Action to Preserve Value and Strengthen Capital Structure","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2024-04-01","type":"trial","source":"GlobeNewswire","summary":"Gritstone bio Announces Positive Preliminary Progression-free Survival and Long-term Circulating Tumor DNA (ctDNA) Data from Phase 2 Portion of Ongoing Phase 2/3 Study of its Personalized Cancer Vacci","headline":"Gritstone bio Announces Positive Preliminary Progression-free Survival and Long-term Circulating Tumor DNA (ctDNA) Data ","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNV3p5OUttQmZKT3Nyb3FuY0N1QzdhRGZOM2VmVWp6T2NySGZ3LXlGWE0tb0J4eWxVWjNKYjBGU3ZSX2VaVXFHOHlZV19pVGpIT0hpYzVsZlQ3Z2NnMHFxTFlOaGlwUFp4Q0R3Ym5BSGcxVXd0RnRWSGtNS0szUTJ5ckM1Q19CNjZzREZ1NjV5bUluQVZ4YzdWZmFqd013dWxjakRzSG5EVkVTdw?oc=5","date":"2024-03-01","type":"trial","source":"BioPharma Dive","summary":"Gritstone to lay off 40% of workforce after costly study delay - BioPharma Dive","headline":"Gritstone to lay off 40% of workforce after costly study delay","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQTlJnOGZORkQwS0ZBNWwwdzA5cEVFczdpNW9TaWFLdUs3YTU2RktnamlVU2xwM0hzRDJQRERYc0NYRVdJelBVMW9Ra2NRZHhZbEtQX1dkOHJSeVV2b1VYMkZrTnRhZjhRZk9KdUZsODN5X29KSEc0UlJiTktMTXNzeThIajhnRi1zNE9xQU9wSUNybHBRSEFTSlVFT0xZQnJPUnNB?oc=5","date":"2024-03-01","type":"pipeline","source":"BioWorld News","summary":"Markets recovering, but too slow for some; Gritstone shaves 40% - BioWorld News","headline":"Markets recovering, but too slow for some; Gritstone shaves 40%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxQOWZxdFE1RFJrTkh5WFdzbF8wRTFqVS12UDlsZ01BVDk5V0JXN1NoNDZkbU5Xd1l6Um5iWHBOVWdSOTRQTHVFQm1Ra2NGMzI2WnMzQTZydlM3Qi01Y0pIaWQyS3JCQ0gtY1BpUmJkSWQ0aUR3MEljQURsOEs2UDIwaC1mam5yRU41NVlPRjJ0SWdCc3dELUtxUGttbno4VlpNYXlLN2hJMmoyYVYxMk9aN29DZUJXWUx6YWFFbFUwM0M5eTVsbmlmMTJHUQ?oc=5","date":"2023-09-27","type":"trial","source":"Reuters","summary":"Gritstone bio wins $433 million US contract for COVID vaccine study - Reuters","headline":"Gritstone bio wins $433 million US contract for COVID vaccine study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE1KdGJGdFFwSU5FLVdKUGtsNkRRQnhMSGtLWjJZc2NpS1M0TngzNGdNMEJxR2JRempCNGJCUTRicVowbV9iM0NFNUlXVG9rZldzcFFMRERISXFZeEk5dHhDRUhCaTA2TUYyNU9YYUFkS1pWeUVQT2VTLQ?oc=5","date":"2022-09-06","type":"pipeline","source":"Pharma Voice","summary":"Innovators: Karin Jooss - Pharma Voice","headline":"Innovators: Karin Jooss","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPdEQya3dNeVItM3BCNGNzSG14a1ozUjktZHJfTWZPdVRxSzEtMkpuWXgybm5KMkpxazlkV1ZfRDJ3TmFMX3J1eU9NTWxkOVB6S3RubmZEa2JENXNJMnh0cy1hVDQxRl9PX1VfUWZFQTZOSllaOTR6YUdidnVaZ3dlLUFUTUpaZzJaTXFIWmlEYkFqZw?oc=5","date":"2018-08-27","type":"deal","source":"Contract Pharma","summary":"bluebird bio, Gritstone Enter Collaboration - Contract Pharma","headline":"bluebird bio, Gritstone Enter Collaboration","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}